Position in JNJ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$319,167,751
+$38,971,732 QoQ
Shares Held
1,305,710
-3.6% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Chevy Chase Trust Holdings, LLC holds $1,529,841,397 across 12 Drug Manufacturers - General names. JNJ ranks #2 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
397,885 | $365,962,685 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,305,710 | $319,167,751 | |
| 3 | ABBV |
AbbVie Inc.
|
904,397 | $196,697,302 | |
| 4 | NVS |
Novartis AG
|
1,049,794 | $160,356,033 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,253,128 | $150,738,766 | |
| 6 | AMGN |
Amgen Inc
|
271,229 | $95,431,922 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
617,014 | $85,993,240 | |
| 8 | PFE |
Pfizer Inc
|
2,839,911 | $79,744,700 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $319,167,751 | 1,305,710 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $280,196,019 | 1,353,931 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $252,220,150 | 1,360,264 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $214,062,017 | 1,401,388 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $230,906,494 | 1,392,345 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $202,337,986 | 1,399,101 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $239,340,093 | 1,476,861 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $219,502,941 | 1,501,799 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $281,051,268 | 1,776,669 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $277,021,491 | 1,767,395 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $290,415,499 | 1,864,626 | Shares | Defined | 2023-10-23 | |
| 2023-06-30 | $331,173,243 | 2,000,805 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $324,315,955 | 2,092,361 | Shares | Defined | 2023-05-17 | |
| 2022-12-31 | $339,387,222 | 1,921,241 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $334,325,224 | 2,046,555 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $350,151,077 | 1,972,571 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $322,221,862 | 1,818,100 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $311,248,178 | 1,819,420 | Shares | Defined | 2022-01-31 | |
| 2021-09-30 | $300,871,108 | 1,862,979 | Shares | Defined | 2021-10-20 | |
| 2021-06-30 | $322,539,668 | 1,957,871 | Shares | Defined | 2021-07-20 | |
| 2021-03-31 | $335,931,892 | 2,044,003 | Shares | Defined | 2021-04-22 | |
| 2020-12-31 | $341,341,954 | 2,168,903 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $333,349,316 | 2,239,047 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $337,734,897 | 2,401,585 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $330,176,554 | 2,517,933 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||